|Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach|
B Spire, S Duran, M Souville, C Leport, F Raffi, JP Moatti
Social science & medicine 54 (10), 1481-1496, 2002
|Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de …|
D Blaise, M Kuentz, C Fortanier, JH Bourhis, N Milpied, L Sutton, JP Jouet, ...
Journal of Clinical Oncology 18 (3), 537-537, 2000
|Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy|
S Duran, M Savès, B Spire, V Cailleton, A Sobel, P Carrieri, D Salmon, ...
Aids 15 (18), 2441-2444, 2001
|Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment|
JP Moatti, MP Carrieri, B Spire, JA Gastaut, JP Cassuto, J Moreau, ...
Aids 14 (2), 151-155, 2000
|Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART|
S Duran, B Spire, F Raffi, V Walter, D Bouhour, V Journot, V Cailleton, ...
HIV clinical trials 2 (1), 38-45, 2001
|Adherence to HAART and its principal determinants in a cohort of Senegalese adults|
I Lanièce, M Ciss, A Desclaux, K Diop, F Mbodj, B Ndiaye, O Sylla, ...
Aids 17, S103-S108, 2003
|The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort|
P Carrieri, V Cailleton, V Le Moing, B Spire, P Dellamonica, E Bouvet, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (3), 232-239, 2001
|AIDS and sexual behaviour in France.|
A Spira, N Bajos, A Bejin, N Beltzer
|Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy|
AD Bouhnik, M Préau, E Vincent, MP Carrieri, H Gallais, G Lepeu, ...
Antivir ther 10 (1), 53-61, 2005
|Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?|
M Schwarzinger, R Flicoteaux, S Cortarenoda, Y Obadia, JP Moatti
PLoS One 5 (4), e10199, 2010
|Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen|
V Le Moing, G Chêne, MP Carrieri, A Alioum, F Brun-Vézinet, L Piroth, ...
Aids 16 (1), 21-29, 2002
|Injecting misuse of buprenorphine among French drug users|
Y Obadia, V Perrin, I Feroni, D Vlahov, JP Moatti
Addiction 96 (2), 267-272, 2001
|Health-related quality of life after 1 year of highly active antiretroviral therapy|
P Carrieri, B Spire, S Duran, C Katlama, D Peyramond, C François, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 32 (1), 38-47, 2003
|Le principe de prévention: le culte de la santé et ses dérives|
P Peretti-Watel, JP Moatti
|Nonadherence among HIV-infected injecting drug users: the impact of social instability.|
AD Bouhnik, M Chesney, P Carrieri, H Gallais, J Moreau, JP Moatti, ...
Journal of acquired immune deficiency syndromes (1999) 31, S149-53, 2002
|Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study|
P Christian, B Laurence, S Bruno, TT Catherine, M Michel, S Marc, ...
HIV clinical trials 4 (2), 121-131, 2003
|Risk perception and social acceptability of technologies: The French case|
S Bastide, JP Moatti, JP Pages, F Fagnani
Risk analysis 9 (2), 215-223, 1989
|Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment …|
MP Carrieri, C Leport, C Protopopescu, JP Cassuto, E Bouvet, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (4), 477-485, 2006
|Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study|
MP Carrieri, F Raffi, C Lewden, A Sobel, C Michelet, V Cailleton, G Chene, ...
Antiviral therapy 8 (6), 585-594, 2003
|Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer|
P Ananian, G Houvenaeghel, C Protiere, P Rouanet, S Arnaud, JP Moatti, ...
Annals of Surgical Oncology 11 (8), 762-771, 2004